C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/37 (2006.01) A61K 31/7088 (2006.01) A61K 39/12 (2006.01) A61K 39/385 (2006.01) A61K 48/00 (2006.01) C07K 14/025 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2500093
The present invention relates to methods and compositions useful in the treatment and prevention of human papilloma virus infections. In particular the invention relates to nucleic acid molecules encoding E1 and/or E2 and vectors suitable for DNA vaccine delivery, and pharmaceutical compositions containing them. Methods for manufacturing said molecules, vectors and composition are also contemplated.
La présente invention concerne des techniques et des compositions qui conviennent pour le traitement et la prévention des infections par le papillomavirus humain. Cette invention concerne, en particulier, des molécules d'acides nucléiques codantes pour E1 et/ou E2 et des vecteurs adaptés pour l'apport de vaccin à ADN et, des compositions pharmaceutiques contenant ces molécules. Cette invention concerne aussi des techniques de fabrication de ces molécules, de ces vecteurs et de cette composition.
Gough Gerald Wayne
Roberts Christopher Michael
Glaxo Group Limited
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Dna vaccine encoding at least two nonstructural early... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dna vaccine encoding at least two nonstructural early..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dna vaccine encoding at least two nonstructural early... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1811223